CYTOMX THERAPEUTICS INC. WKN: A14158 ISIN: US23284F1057 Kürzel: CTMX Forum: Aktien Thema: Hauptdiskussion
The offering was led by Longitude Capital and also included participation from OrbiMed, Venrock Healthcare Capital Partners, Vivo Capital, RTW Investments, and a large investment management firm, among other funds. Jefferies and Piper Sandler are acting as joint book-running managers for the offering.
The offering was led by Longitude Capital and also included participation from OrbiMed, Venrock Healthcare Capital Partners, Vivo Capital, RTW Investments, and a large investment management firm, among other funds. Jefferies and Piper Sandler are acting as joint book-running managers for the offering.
|
|
Thema | ||
|---|---|---|---|
| 1 | Xpeng | -3,45 % | |
| 2 | für alle, die es ehrlich meinen beim Traden. | ||
| 3 | VONOVIA Hauptdiskussion | -0,97 % | |
| 4 | DAX Prognose / Germany 40 | -0,02 % | |
| 5 | MICROSTRATEGY Hauptdiskussion | -1,11 % | |
| 6 | Strategy B | -1,11 % | |
| 7 | Metaplanet | +0,72 % | |
| 8 | Börsentheater | ||
| 9 | DeFi Technologies: Eine Perle? | +11,67 % | |
| 10 | HELLOFRESH SE INH O.N. Hauptdiskussion | -2,16 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | Xpeng | -3,45 % | |
| 2 | VONOVIA Hauptdiskussion | -0,97 % | |
| 3 | MICROSTRATEGY Hauptdiskussion | -1,11 % | |
| 4 | Metaplanet | +0,72 % | |
| 5 | Strategy B | -1,11 % | |
| 6 | DeFi Technologies: Eine Perle? | +11,67 % | |
| 7 | HELLOFRESH SE INH O.N. Hauptdiskussion | -2,16 % | |
| 8 | NVIDIA Hauptdiskussion | -0,73 % | |
| 9 | NEL ASA Hauptdiskussion | -1,03 % | |
| 10 | Gamestop, das Ende naht | +0,74 % | Alle Diskussionen |